Biomea Fusion outlines 2026 diabetes and obesity drug ...
5 days ago · Biomea Fusion outlines 2026 diabetes and obesity drug development plans Company News Published 01/12/2026, 01:35 PM 0
A New Era of Biotech Innovation: Market Impact of AI-Based ...
3 days ago · By 2026, the biotechnology industry is undergoing unprecedented changes due to the convergence of artificial intelligence and genomics, with personalized treatments and AI-based drug …
Diabetic Neuropathy Drug Development Services - Ace Therapeutics
Ace Therapeutics provides comprehensive, end-to-end preclinical services for diabetic neuropathy drug development.
EMA & FDA issue joint AI guiding principles for drug developers
2 days ago · Guiding Principles of Good AI Practice in Drug Development January 2026 Artificial Intelligence (AI) is rapidly transforming how drugs and medicines are discovered, developed, …
US, European regulators set principles for 'good AI practice ...
4 days ago · Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible use of artificial intelligence in developing …